Literature DB >> 3603104

Severe hypophosphatemia in a general hospital population.

A L King, D A Sica, G Miller, S Pierpaoli.   

Abstract

We reviewed 16,621 blood chemistry samples taken over a 12-week period; 34 patients with severe hypophosphatemia (serum phosphate level less than or equal to 1.0 mg/dl) were identified, for an incidence of 0.24%. The most common causes of severe hypophosphatemia (SH) in this population were infusion of dextrose solutions (73%), nutritional recovery syndrome (50%), phosphate-binding antacids (50%), and alcohol withdrawal (32%). In general, the patients were normophosphatemic at the time of hospitalization, and SH occurred early in the hospital course. All of the patients responded to the drop in serum phosphate by renal conservation of phosphate (Tm PO4/GFR less than 1.0 mg/dl GFR). Patients required small doses of phosphate to achieve a serum level above 2.0 mg/dl, with 50% of the population receiving less than 25 mmol of replacement therapy. Regardless of the route or amount of replacement therapy given, the course of SH was typically short and without sequelae.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3603104     DOI: 10.1097/00007611-198707000-00008

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  Successful Localization Using 68Ga-DOTATOC PET/CT of a Phosphaturic Mesenchymal Tumor Causing Osteomalacia in a Patient with Concurrent Follicular Lymphoma.

Authors:  Sejin Ha; Sujin Park; Hyunji Kim; Heounjeong Go; Seung Hun Lee; Ji Yoon Choi; Jung Yong Hong; Jin-Sook Ryu
Journal:  Nucl Med Mol Imaging       Date:  2018-09-12

Review 2.  Treatment of hypophosphatemia in the intensive care unit: a review.

Authors:  Daniël A Geerse; Alexander J Bindels; Michael A Kuiper; Arnout N Roos; Peter E Spronk; Marcus J Schultz
Journal:  Crit Care       Date:  2010-08-03       Impact factor: 9.097

3.  Occurrence of refeeding syndrome in adults started on artificial nutrition support: prospective cohort study.

Authors:  Alan Rio; Kevin Whelan; Louise Goff; Dianne Patricia Reidlinger; Nigel Smeeton
Journal:  BMJ Open       Date:  2013-01-11       Impact factor: 2.692

4.  Hyperphosphatemia Is an Independent Risk Factor for Mortality in Critically Ill Patients: Results from a Cross-Sectional Study.

Authors:  Dominik G Haider; Gregor Lindner; Michael Wolzt; Sufian S Ahmad; Thomas Sauter; Alexander Benedikt Leichtle; Georg-Martin Fiedler; Valentin Fuhrmann; Aristomenis K Exadaktylos
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.